280 related articles for article (PubMed ID: 25242701)
1. Botulinum toxin A for children with salivary control problems.
Montgomery J; McCusker S; Hendry J; Lumley E; Kubba H
Int J Pediatr Otorhinolaryngol; 2014 Nov; 78(11):1970-3. PubMed ID: 25242701
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
Mahadevan M; Gruber M; Bilish D; Edwards K; Davies-Payne D; van der Meer G
Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
[TBL] [Abstract][Full Text] [Related]
3. Managing children with sialorrhoea (drooling): Experience from the first 301 children in our saliva control clinic.
Montgomery J; McCusker S; Lang K; Grosse S; Mace A; Lumley R; Kubba H
Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():33-9. PubMed ID: 27240493
[TBL] [Abstract][Full Text] [Related]
4. [Submandibular gland resection for the management of sialorrhea in paediatric patients with cerebral palsy and unresponsive to type A botullinum toxin. Pilot study].
Hernández-Palestina MS; Cisneros-Lesser JC; Arellano-Saldaña ME; Plascencia-Nieto SE
Cir Cir; 2016; 84(6):459-468. PubMed ID: 27221328
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound-Guided Botulinum Toxin Type A Salivary Gland Injection in Children for Refractory Sialorrhea: 10-Year Experience at a Large Tertiary Children's Hospital.
Lungren MP; Halula S; Coyne S; Sidell D; Racadio JM; Patel MN
Pediatr Neurol; 2016 Jan; 54():70-5. PubMed ID: 26706481
[TBL] [Abstract][Full Text] [Related]
6. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
Banerjee KJ; Glasson C; O'Flaherty SJ
Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
[TBL] [Abstract][Full Text] [Related]
7. Tolerance of salivary gland botulinum toxin A injection under local anesthesia for the treatment of sialorrhea in children: An observational study.
Toulemonde P; Maltezeanu A; Broucqsault H; Fayoux P
Eur Ann Otorhinolaryngol Head Neck Dis; 2022 Mar; 139(2):77-81. PubMed ID: 34217684
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
Wilken B; Aslami B; Backes H
Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
[TBL] [Abstract][Full Text] [Related]
9. Safety of Ultrasound-Guided Botulinum Toxin Injections for Sialorrhea as Performed by Pediatric Otolaryngologists.
Shariat-Madar B; Chun RH; Sulman CG; Conley SF
Otolaryngol Head Neck Surg; 2016 May; 154(5):924-7. PubMed ID: 26908558
[TBL] [Abstract][Full Text] [Related]
10. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.
Savarese R; Diamond M; Elovic E; Millis SR
Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333
[TBL] [Abstract][Full Text] [Related]
11. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
Gonzalez-L MD; Martinez C; Bori Y Fortuny I; Suso-Vergara S
Am J Phys Med Rehabil; 2017 Feb; 96(2):68-76. PubMed ID: 28099276
[TBL] [Abstract][Full Text] [Related]
12. Role of botulinum toxin A injection into the submandibular salivary glands as an assessment for the subsequent removal of the submandibular glands in the management of children with sialorrhoea.
Sidebottom AJ; May JE; Madahar AK
Br J Oral Maxillofac Surg; 2013 Mar; 51(2):113-6. PubMed ID: 22658501
[TBL] [Abstract][Full Text] [Related]
13. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy.
Suskind DL; Tilton A
Laryngoscope; 2002 Jan; 112(1):73-81. PubMed ID: 11802042
[TBL] [Abstract][Full Text] [Related]
14. Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.
Meijer JW; van Kuijk AA; Geurts AC; Schelhaas HJ; Zwarts MJ
Am J Phys Med Rehabil; 2008 Apr; 87(4):321-4. PubMed ID: 18303472
[TBL] [Abstract][Full Text] [Related]
15. Onabotulinumtoxin A Treatment of Drooling in Children with Cerebral Palsy: A Prospective, Longitudinal Open-Label Study.
Møller E; Pedersen SA; Vinicoff PG; Bardow A; Lykkeaa J; Svendsen P; Bakke M
Toxins (Basel); 2015 Jun; 7(7):2481-93. PubMed ID: 26134257
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study.
Wu KP; Ke JY; Chen CY; Chen CL; Chou MY; Pei YC
J Child Neurol; 2011 Jul; 26(7):838-43. PubMed ID: 21551374
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series.
Jongerius PH; Rotteveel JJ; van den Hoogen F; Joosten F; van Hulst K; Gabreëls FJ
Eur J Pediatr; 2001 Aug; 160(8):509-12. PubMed ID: 11548191
[TBL] [Abstract][Full Text] [Related]
18. Treatment of sialorrhoea with repeated ultrasound-guided injections of botulinum toxin A into the parotid and submandibular glands.
Taib BG; Williams SP; Sood S; Ung K; Nixon PP; Sharma R
Br J Oral Maxillofac Surg; 2019 Jun; 57(5):442-448. PubMed ID: 31010597
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety and efficacy data on botulinum toxin type A: an injection for sialorrhea.
Chan KH; Liang C; Wilson P; Higgins D; Allen GC
JAMA Otolaryngol Head Neck Surg; 2013 Feb; 139(2):134-8. PubMed ID: 23429943
[TBL] [Abstract][Full Text] [Related]
20. Botox(®) to reduce drooling in a paediatric population with neurological impairments: a Phase I study.
Hay N; Penn C
Int J Lang Commun Disord; 2011; 46(5):550-63. PubMed ID: 21899672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
